sterile_file

TL3 Regular · Wolverhampton, UK

Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.

Joined 20 November 2024 · last posted 23h · groups: analytical-chemists

127 posts, newest first. Showing up to 150.

Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #57 · Pharmacology › Receptor biology · 27 Jul 2026 · 6 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
Follow-up: How compounding permissions changed when supply normalised Replied, post #73 · Sourcing › Regulatory · 25 Jul 2026 · 0 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #52 · Compounds › Repair & healing peptides · 25 Jul 2026 · 1 like On post #48 — agreed on the reasoning, with one qualification. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and…
Sleep quality changes during weight loss Replied, post #28 · Wellbeing › Sleep · 24 Jul 2026 · 1 like Coming back to post #26, because the follow-up matters more than the original answer. Appetite suppression and nighttime eating: if nighttime eating was a pattern,…
Request: a per-category review queue Replied, post #119 · Meta › Feature requests · 21 Jul 2026 · 0 likes Feature scope: some requests are for the site itself (search, filtering, navigation). Some are for the documentation (new topics, different formats). Scope helps…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #96 · Analytics › Impurities & related substances · 20 Jul 2026 · 0 likes I read post #94 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
Conditions that change the calculus rather than forbidding it Replied, post #30 · Safety › Contraindications · 15 Jul 2026 · 0 likes post #29 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #90 · Sourcing › Independent verification · 14 Jul 2026 · 14 likes Coming back to post #88, because the follow-up matters more than the original answer. Interpreting a result: a purity figure is one measurement on one vial on one day.…
Revisiting: What pooling buys you and what it destroys Replied, post #90 · Evidence › Meta-analyses · 13 Jul 2026 · 12 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
What changed in 2026, by region — does this still hold? Replied, post #22 · Access › International · 12 Jul 2026 · 9 likes Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #55 · Practice › Administration · 11 Jul 2026 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #3 · Start Here › How to Ask · 7 Jul 2026 · 22 likes Picking up post #2: that is the part I would want checked first. Lab result questions: state the result, the reference interval, and what else is on the same panel. A…
Athletes in weight-category sports: a different risk calculus Replied, post #15 · Clinical › Special populations · 6 Jul 2026 · 22 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Follow-up: Interpreting a composition change that is within the error bars Replied, post #3 · marked as the solution · Outcomes › Body composition · 4 Jul 2026 · 6 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #83 · Compounds › Repair & healing peptides · 2 Jul 2026 · 5 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
Common supplements people ask about, assessed one at a time Replied, post #4 · Practice › Interactions · 2 Jul 2026 · 13 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
Dizziness on standing: the ordinary explanation first — one year on Replied, post #12 · Nutrition & Training › Hydration & electrolytes · 28 Jun 2026 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Alcohol: what is documented and what is folklore Replied, post #74 · Practice › Interactions · 24 Jun 2026 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Insurance and replacement policies, compared Replied, post #24 · Sourcing › Logistics · 16 Jun 2026 · 3 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
Carryover and the ghost peak from last week's standard — what changed since Replied, post #35 · Analytics › HPLC & UHPLC · 15 Jun 2026 · 23 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
Pooling trials with different estimands Replied, post #17 · Evidence › Meta-analyses · 10 Jun 2026 · 22 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
What changed in 2026, by region — does this still hold? Replied, post #13 · Access › International · 5 Jun 2026 · 9 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
Blind submission and why it changes minds — the long version Replied, post #111 · Sourcing › Independent verification · 1 Jun 2026 · 0 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Bioimpedance and hydration: why the number moves Replied, post #50 · Outcomes › Body composition · 25 May 2026 · 2 likes Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is maintained, metabolic rate is usually maintained better than…
Alcohol: what is documented and what is folklore Replied, post #23 · Practice › Interactions · 22 May 2026 · 32 likes Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can overlap and additive. Taking them separately or…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #76 · Compounds › Tirzepatide · 22 May 2026 · 1 like SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Search filters: what is missing Replied, post #60 · Meta › Site feedback · 22 May 2026 · 8 likes Accessibility: screen readers, keyboard navigation, contrast, font size — if something is not accessible to you, report it. Accessibility matters.
How much fluid is actually needed, and how you would know Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 21 May 2026 · 23 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
How to ask about something you suspect is a bad idea Replied, post #88 · Start Here › How to Ask · 14 May 2026 · 16 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Private prescribing in the UK: what is actually involved Replied, post #10 · Regional › UK & Ireland · 6 May 2026 · 15 likes I read post #8 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
Request: show the solution author in the topic list — what changed since Replied, post #58 · Meta › Feature requests · 3 May 2026 · 27 likes Tracking: staff will update the status of feature requests (under consideration, planned, implemented, declined). Checking back lets you know the fate of your suggestion.
Semaglutide and alcohol: what is actually documented Started this topic · Compounds › Semaglutide · 24 Apr 2026 · 0 likes Posting this under the heading it deserves: Semaglutide and alcohol: what is actually documented Everything below is what sits behind that. I have seen STEP 8 ( JAMA ,…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #39 · Evidence › Journal club · 24 Apr 2026 · 13 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
[2026 update] What a purity-only report leaves out Replied, post #102 · Sourcing › Independent verification · 24 Apr 2026 · 19 likes Coming back to post #100, because the follow-up matters more than the original answer. PeptideMeter: purity analysis plus structured, dated supplier verification…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #66 · Practice › Reconstitution · 22 Apr 2026 · 31 likes post #65 is right about the mechanism and I think understates the practical bit. Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects…
Tracking intake honestly when appetite is absent Started this topic · Nutrition & Training › Protein & intake · 13 Apr 2026 · 0 likes On the subject in the title: Tracking intake honestly when appetite is absent Working notes rather than a conclusion. Longitudinal report with the method stated,…
[2026 update] Composite endpoints and the component doing the work Replied, post #57 · Evidence › Trials · 5 Apr 2026 · 1 like Coming back to post #55, because the follow-up matters more than the original answer. Dropout is information: high dropout rates can indicate tolerability problems or…
Blind submission and why it changes minds — the long version Replied, post #8 · Sourcing › Independent verification · 3 Apr 2026 · 23 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Type 2 diabetes and the largest part of the evidence base Replied, post #49 · Clinical › Comorbidities · 30 Mar 2026 · 11 likes post #48 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #27 · Analytics › COA interpretation · 29 Mar 2026 · 4 likes On post #23 — agreed on the reasoning, with one qualification. Counter-ion form is crucial: peptides are isolated as salts, most often trifluoroacetate from…
The headache that turns out to be dehydration — the long version Replied, post #11 · Nutrition & Training › Hydration & electrolytes · 19 Mar 2026 · 19 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
Amylin receptor signalling and satiety — what changed since Replied, post #47 · Pharmacology › Receptor biology · 19 Mar 2026 · 26 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #18 · Analytics › HPLC & UHPLC · 14 Mar 2026 · 0 likes Picking up post #15: that is the part I would want checked first. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher…
A single out-of-range value on an otherwise normal panel Replied, post #21 · Clinical › Bloodwork · 8 Mar 2026 · 4 likes This follows post #18 rather than contradicting it. Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening.…
Second pass at: Identical chromatograms across two different lots Replied, post #36 · Sourcing › Red flags · 1 Mar 2026 · 1 like I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #60 · Outcomes › Body composition · 27 Feb 2026 · 4 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #6 · Pharmacology › Formulation chemistry · 27 Feb 2026 · 0 likes Fill volume and headspace: the amount of solution in a vial and the air above it affect how much the solution is exposed to oxygen during storage. Less headspace means…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #132 · Access › International · 26 Feb 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
[2026 update] Composite endpoints and the component doing the work Replied, post #13 · Evidence › Trials · 26 Feb 2026 · 3 likes Coming back to post #11, because the follow-up matters more than the original answer. Absolute numbers, not just relative: a 30% relative reduction tells you the ratio…
Journal club: LEADER as the historical anchor Replied, post #39 · Evidence › Journal club · 25 Feb 2026 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Managing an unplanned gap in supply Replied, post #40 · Access › Shortages · 23 Feb 2026 · 18 likes Worth separating two things that post #36 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Forced degradation studies: designing one that is informative Replied, post #10 · Analytics › Method validation · 22 Feb 2026 · 30 likes Worth separating two things that post #6 runs together. Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay…
Preprint servers and what screening they do Replied, post #63 · Evidence › Preprints · 21 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #53 · Analytics › Impurities & related substances · 17 Feb 2026 · 11 likes Incomplete deprotection: mass higher by the protecting group mass. Usually markedly later eluting. A synthesis artifact from incomplete removal of protecting groups.
[2026 update] Composite endpoints and the component doing the work Replied, post #2 · Evidence › Trials · 11 Feb 2026 · 7 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
Residual solvents and scavengers: what is looked for — what changed since Replied, post #6 · marked as the solution · Analytics › Impurities & related substances · 9 Feb 2026 · 32 likes Picking up post #3: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #29 · Evidence › Trials · 6 Feb 2026 · 0 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #23 · Sourcing › Independent verification · 2 Feb 2026 · 17 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Second pass at: What pooling buys you and what it destroys Replied, post #12 · Evidence › Meta-analyses · 24 Jan 2026 · 33 likes Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether the pooled estimate changes. Robust results…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #67 · Regional › UK & Ireland · 14 Jan 2026 · 0 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #7 · Practice › Storage & stability · 24 Dec 2025 · 0 likes Picking up post #4: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #23 · Pharmacology › Receptor biology · 22 Dec 2025 · 24 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: Metformin co-administration and additive GI effects Replied, post #16 · Practice › Interactions · 9 Dec 2025 · 4 likes post #15 answers the question as asked. The question underneath it is different. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #30 · Access › Pricing · 5 Dec 2025 · 0 likes post #29 is right about the mechanism and I think understates the practical bit. Biosimilars and future generics: as patents expire, biosimilar and generic versions…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #103 · Documentation › Doc review · 30 Nov 2025 · 3 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #37 · Compounds › Other compounds · 23 Nov 2025 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
[2026 update] What steady state means for the decision to escalate Replied, post #76 · Practice › Dosing & titration · 13 Nov 2025 · 7 likes Worth separating two things that post #72 runs together. The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The…
Constipation management, with a dietitian's contribution Started this topic · Practice › Side effects · 4 Nov 2025 · 5 likes Posting this under the heading it deserves: Constipation management, with a dietitian's contribution Everything below is what sits behind that. Practical question with…
Pooling trials with different estimands — what changed since Replied, post #46 · Evidence › Meta-analyses · 4 Nov 2025 · 7 likes post #45 is right about the mechanism and I think understates the practical bit. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion…
Follow-up: The decimal-point error, and the habit that catches it Replied, post #89 · Practice › Reconstitution · 31 Oct 2025 · 1 like This follows post #86 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #11 · Practice › Side effects · 28 Oct 2025 · 9 likes Picking up post #8: that is the part I would want checked first. Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most…
Publishing an inconvenient result: a case study — the long version Replied, post #17 · Sourcing › Independent verification · 24 Oct 2025 · 1 like Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
Where to report an adverse event officially, by region — a second dataset Replied, post #22 · Safety › Adverse events · 15 Oct 2025 · 8 likes Serious and unexpected events are the ones to document and report. Serious means hospitalization-level serious. Unexpected means not in the drug's known profile. Both…
A comparison of home results against a laboratory result on the same vial Replied, post #37 · Analytics › Home & field testing · 15 Sep 2025 · 3 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #52 · Practice › Dosing & titration · 14 Sep 2025 · 0 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
Reading an interaction checker output critically Replied, post #4 · Practice › Interactions · 11 Sep 2025 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
System suitability injections: if they failed, the run did not happen Replied, post #25 · Analytics › HPLC & UHPLC · 23 Aug 2025 · 31 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #83 · Data & Tools › Calculators · 15 Aug 2025 · 6 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
Request: a diff view for wiki revisions — the long version Replied, post #29 · Meta › Feature requests · 11 Aug 2025 · 3 likes Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging tradeoffs shows you have thought through the implications.
Publishing an inconvenient result: a case study Replied, post #58 · Sourcing › Independent verification · 31 Jul 2025 · 13 likes This follows post #55 rather than contradicting it. Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is…
When to stop reading forums, including this one Replied, post #10 · Wellbeing › Mental health · 29 Jul 2025 · 4 likes Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be psychologically complex. Some of that is positive;…
Coming back to: Request: tag synonyms surfaced in search Replied, post #3 · marked as the solution · Meta › Feature requests · 26 Jun 2025 · 7 likes Coming back to the opening post, because the follow-up matters more than the original answer. Community support: if other people support your request, they can reply…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #17 · Sourcing › Vendor reports · 26 Jun 2025 · 28 likes Coming back to post #15, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #74 · Clinical › Comorbidities · 25 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Follow-up: Requesting a page: what makes a good request Replied, post #47 · Documentation › Wiki requests · 11 Jun 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #15 · Evidence › Trials · 5 Jun 2025 · 29 likes Coming back to post #13, because the follow-up matters more than the original answer. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the…
Coming back to: Getting a referral rather than a refusal Replied, post #33 · Clinical › Prescriber conversations · 5 Jun 2025 · 0 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
Follow-up: What other technical communities get right that we do not Replied, post #118 · Lounge › Off topic · 2 Jun 2025 · 10 likes Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Follow-up: What other technical communities get right that we do not Replied, post #107 · Lounge › Off topic · 23 May 2025 · 23 likes Picking up post #104: that is the part I would want checked first. Personal stories: if you want to talk about what led you to this compound, your journey, or how the…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #41 · Clinical › Comorbidities · 16 May 2025 · 0 likes Worth separating two things that post #37 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #112 · Compounds › Cagrilintide & amylin analogues · 9 May 2025 · 12 likes post #111 is right about the mechanism and I think understates the practical bit. Cagrilintide alone is discussed less than in combination because the published data is…
Micronutrient status when intake falls substantially Replied, post #4 · Clinical › Bloodwork · 8 May 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more…
DXA precision and the least significant change for lean mass — the long version Replied, post #12 · Outcomes › Body composition · 7 May 2025 · 1 like post #11 answers the question as asked. The question underneath it is different. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research.…
[2026 update] Dose numbers across compounds are not on the same scale Replied, post #11 · Practice › Dosing & titration · 21 Apr 2025 · 28 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
Coverage for the indication versus for the drug Replied, post #36 · Access › Insurance & coverage · 20 Apr 2025 · 3 likes Worth separating two things that post #32 runs together. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but…
Review cadence: how often is a page actually re-checked? Replied, post #16 · Documentation › Doc review · 11 Apr 2025 · 27 likes post #15 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Retatrutide dose escalation in the published trials Replied, post #115 · Compounds › Retatrutide · 10 Apr 2025 · 14 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
A promotion I argued against, and why I lost Replied, post #149 · Documentation › Doc review · 27 Mar 2025 · 1 like Evidence synthesis requests: if you think a page should summarise the state of evidence on a question, and you think the information exists but is scattered, suggest…
Distinguishing a deletion sequence by mass alone — the long version Replied, post #10 · Analytics › Mass spectrometry · 21 Mar 2025 · 30 likes I read post #8 twice before replying, because I had assumed the opposite. What mass accuracy establishes: the measured mass is consistent with a specific composition.…
Charge states for a 4 kDa peptide, worked through Replied, post #147 · Analytics › Mass spectrometry · 18 Mar 2025 · 0 likes On post #143 — agreed on the reasoning, with one qualification. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #86 · Sourcing › Regulatory · 3 Mar 2025 · 26 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption. The…
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #50 · Evidence › Journal club · 3 Mar 2025 · 6 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
Coming back to: Official shortage notices and what they authorise Replied, post #27 · Access › Shortages · 19 Feb 2025 · 5 likes Worth separating two things that post #23 runs together. Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the…
A promotion I argued against, and why I lost Replied, post #86 · Documentation › Doc review · 5 Feb 2025 · 1 like Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
Review: a draft on reconstitution arithmetic, with objections Replied, post #2 · Documentation › Doc review · 24 Jan 2025 · 14 likes the opening post is right about the mechanism and I think understates the practical bit. Multilingual versions: if a maintained page should exist in another language,…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #152 · Clinical › Prescriber conversations · 20 Jan 2025 · 28 likes I read post #150 twice before replying, because I had assumed the opposite. Preparing for an appointment: bring recent bloodwork, a list of current medications with…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #97 · Evidence › Journal club · 19 Jan 2025 · 7 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #19 · Evidence › Meta-analyses · 15 Jan 2025 · 0 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #119 · Access › Insurance & coverage · 13 Jan 2025 · 0 likes Documentation your clinician can provide: letters from clinicians describing why standard treatments have failed or are contraindicated are often exactly what an…
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #25 · Compounds › Secretagogues & GH axis · 10 Jan 2025 · 0 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
Follow-up: Individual participant data versus aggregate data Replied, post #67 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
Turnaround times and what they mean for a decision — one year on Replied, post #25 · Sourcing › Independent verification · 28 Dec 2024 · 6 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
Building a sensible monitoring schedule with your prescriber Replied, post #101 · Clinical › Bloodwork · 23 Dec 2024 · 3 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #62 · Compounds › Tirzepatide · 30 Nov 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #4 · Devices › Syringes & needles · 24 Nov 2024 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the…
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #23 · Practice › Reconstitution · 23 Nov 2024 · 0 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #105 · Clinical › Prescriber conversations · 21 Nov 2024 · 21 likes Worth separating two things that post #101 runs together. Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration,…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #35 · Access › Insurance & coverage · 21 Nov 2024 · 1 like Picking up post #32: that is the part I would want checked first. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
When "no data" is the complete and final answer Replied, post #23 · Compounds › Other compounds · 18 Nov 2024 · 0 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
EMA product information as a primary source — does this still hold? Replied, post #108 · Regional › European Union · 18 Nov 2024 · 5 likes Germany: BfArM implements EU framework. Statutory insurance (the majority) excludes "lifestyle medicines" including weight management. Private prescription is common.…
When to suspect the method rather than the sample Replied, post #28 · Analytics › Method validation · 25 Oct 2024 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #15 · Clinical › Comorbidities · 2 Oct 2024 · 6 likes post #14 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #94 · Sourcing › Independent verification · 29 Sep 2024 · 2 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #48 · Evidence › Journal club · 19 Sep 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
The topic list is dense — is that deliberate? Replied, post #23 · Meta › Site feedback · 8 Sep 2024 · 0 likes post #22 answers the question as asked. The question underneath it is different. Display issues: broken layouts, images not loading, text overlapping — report with the…
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #6 · Clinical › Bloodwork · 2 Sep 2024 · 6 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Chronic kidney disease and the FLOW result Replied, post #15 · Clinical › Comorbidities · 14 Aug 2024 · 15 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…